Node: Incorrect Authorization
CVE-2023-23918 is a high-severity incorrect authorization vulnerability in Node from Node.js, with a CVSS 3.1 base score of 7.5 out of 10. It can be exploited remotely over the network by an unauthenticated attacker, without any action from a user. The record lists versions 4.*, 5.*, 6.* as the first without the flaw, so updating Node to one of those releases or later removes the exposure. There is no confirmed exploitation so far. EPSS estimates a 2.02% chance of exploitation within 30 days, higher than 81% of scored CVEs.
High severity with no evidence of exploitation so far.
What to do
- Update Node to 4.* or 5.* or 6.* or 7.*, whichever matches your release line, or a later version.
- Update Node.js to 14.21.3 or 16.19.1 or 18.14.1 or 19.6.1, whichever matches your release line, or a later version.
- Read the advisory on nodejs.org for workarounds and exact fixed builds.
- Until you can update, restrict network access to the affected service so it is not reachable from untrusted networks.
Affected products and versions
| Vendor | Product | Affected versions | Fixed in |
|---|---|---|---|
| Node.js | Node | 4.0 up to, but not including, 4.*; 5.0 up to, but not including, 5.*; 6.0 up to, but not including, 6.*; 7.0 up to, but not including, 7.*; 8.0 up to, but not including, 8.*; 9.0 up to, but not including, 9.*; 10.0 up to, but not including, 10.*; 11.0 up to, but not including, 11.*; and 8 more ranges | 4.*, 5.*, 6.*, 7.*, 8.*, 9.* |
| Node.js | Node.js | 14.0.0 through 14.14.0; 14.0.0 up to, but not including, 14.21.3; 16.0.0 through 16.12.0; 16.0.0 up to, but not including, 16.19.1; 18.0.0 through 18.11.0; 18.0.0 up to, but not including, 18.14.1; 19.0.0 up to, but not including, 19.6.1 | 14.21.3, 16.19.1, 18.14.1, 19.6.1 |
Version data comes from the organisation that assigned the CVE. Confirm against the vendor advisory before deciding you are unaffected.
How the severity score breaks down
- Attack vector
- NetworkCan be exploited remotely over a network, including the internet.
- Attack complexity
- LowNo special conditions are needed; the attack works reliably.
- Privileges required
- NoneNo account or login is needed.
- User interaction
- NoneNo action by a victim is required.
- Scope
- UnchangedImpact stays within the vulnerable component.
- Confidentiality
- HighAll data handled by the component can be read.
- Integrity
- NoneNothing can be modified.
- Availability
- NoneAvailability is not affected.
Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N. Scored by NVD.
| Scoring system | Score | Severity | Scored by |
|---|---|---|---|
| CVSS 3.1 | 7.5 | High | NVD |
| CVSS 3.1 | 7.5 | High | CISA (ADP) |
Official description
A privilege escalation vulnerability exists in Node.js <19.6.1, <18.14.1, <16.19.1 and <14.21.3 that made it possible to bypass the experimental Permissions (https://nodejs.org/api/permissions.html) feature in Node.js and access non authorized modules by using process.mainModule.require(). This only affects users who had enabled the experimental permissions option with --experimental-policy.
Source: the CVE record as published by its numbering authority, via NVD and CVE.org.
The underlying weakness: Incorrect Authorization
The product performs an authorization check when an actor attempts to access a resource or perform an action, but it does not correctly perform the check.
How developers prevent this class of flaw
- Divide the product into anonymous, normal, privileged, and administrative areas. Reduce the attack surface by carefully mapping roles with data and functionality. Use role-based access control (RBAC) to enforce the roles at the appropriate boundaries. Note that this approach may not protect against horizontal authorization, i.e., it will not protect a user from attacking others with the same role.
- Ensure that access control checks are performed related to the business logic. These checks may be different than the access control checks that are applied to more generic resources such as files, connections, processes, memory, and database records. For example, a database may restrict access for medical records to a specific database user, but each record might only be intended to be accessible to the patient and the patient's doctor.
- Use a vetted library or framework that does not allow this weakness to occur or provides constructs that make this weakness easier to avoid. For example, consider using authorization frameworks such as the JAAS Authorization Framework and the OWASP ESAPI Access Control feature.
Timeline
- CVE record published.
- CISA published its SSVC assessment (exploitation: none, automatable: yes, technical impact: partial).
- Record last changed materially (score, affected products, status or references).
References
Other references
Other vulnerabilities in Node
- 7.5 High severity
- 7.5 High severity
- 8.1 High severity
- 7.5 High severity
- 7.5 High severity
- 8.1 High severity
Recent Incorrect Authorization vulnerabilities
- 7.8 High severity
- 8.5 High severity
- 7.8 High severity
- 7.3 High severity
- 8.1 High severity
- 8.8 High severity
Spotted an error? Tell us.